Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
50.25B
Market cap50.25B
Price-Earnings ratio
48.95
Price-Earnings ratio48.95
Dividend yield
Dividend yield
Average volume
4.07M
Average volume4.07M
High today
$89.76
High today$89.76
Low today
$86.89
Low today$86.89
Open price
$89.30
Open price$89.30
Volume
8.14M
Volume8.14M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

Edwards Lifesciences(EW) stock is priced at $87.27, giving the company a market capitalization of 50.25B. It carries a P/E multiple of 48.95.

On 2026-07-15, Edwards Lifesciences(EW) stock moved within a range of $86.89 to $89.76. With shares now at $87.27, the stock is trading +0.4% above its intraday low and -2.8% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 8.14M, versus its average volume of 4.07M.

The stock's 52-week range extends from a low of $72.30 to a high of $96.29.

The stock's 52-week range extends from a low of $72.30 to a high of $96.29.

EW News

TipRanks 11h
Edwards Lifesciences price target raised to $105 from $100 at Mizuho

Mizuho raised the firm’s price target on Edwards Lifesciences (EW) to $105 from $100 and keeps an Outperform rating on the shares. The firm adjusted targets in...

MarketWatch 1d
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch

...

Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
25.8%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.